HMOX1 and cyclic hematopoiesis: Guo et al. [32] showed that deferoxamine, a ferroptosis inhibitor, could effectively inhibit mouse CH ferroptosis induced by IL-1β or iron overload, and promote the over-expression and nuclear translocation of Nrf2 and its downstream effector HO-1.